ArticleActa pharmacologica Sinica2023

Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities.

Hua-Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.